NO965516L - Sterolderivater anvendt til regulering av meiose - Google Patents

Sterolderivater anvendt til regulering av meiose

Info

Publication number: NO965516L
Authority: NO; Norway
Prior art keywords: sterol derivatives; derivatives used; regulate meiosis; meiosis; regulate
Prior art date: 1994-06-23

Application number

NO965516A

Other languages

English (en)

Other versions

NO965516D0 (no

NO314534B1 (no

Inventor

Anne Grete Byskov

Claus Yding Andersen

Lars Nordholm

Henning Thoegersen

Ole Wassmann

Ivan Verner Diers

Erling Guddal

Original Assignee

Novo Nordisk As

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1994-06-23

Filing date

1996-12-20

Publication date

1997-02-21

1996-12-20 Application filed by Novo Nordisk As filed Critical Novo Nordisk As

1996-12-20 Publication of NO965516D0 publication Critical patent/NO965516D0/no

1997-02-21 Publication of NO965516L publication Critical patent/NO965516L/no

2003-04-07 Publication of NO314534B1 publication Critical patent/NO314534B1/no

Links

229930182558 Sterol Natural products 0.000 title abstract 2
150000003432 sterols Chemical class 0.000 title abstract 2
235000003702 sterols Nutrition 0.000 title abstract 2
230000021121 meiosis Effects 0.000 title 1
239000003814 drug Substances 0.000 abstract 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J43/00—Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton
- C07J43/003—Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton not condensed
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J51/00—Normal steroids with unmodified cyclopenta(a)hydrophenanthrene skeleton not provided for in groups C07J1/00 - C07J43/00
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J53/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton has been modified by condensation with a carbocyclic rings or by formation of an additional ring by means of a direct link between two ring carbon atoms, including carboxyclic rings fused to the cyclopenta(a)hydrophenanthrene skeleton are included in this class
- C07J53/001—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton has been modified by condensation with a carbocyclic rings or by formation of an additional ring by means of a direct link between two ring carbon atoms, including carboxyclic rings fused to the cyclopenta(a)hydrophenanthrene skeleton are included in this class spiro-linked
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J9/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of more than two carbon atoms, e.g. cholane, cholestane, coprostane

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
General Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Pharmacology & Pharmacy (AREA)
Bioinformatics & Cheminformatics (AREA)
Animal Behavior & Ethology (AREA)
Engineering & Computer Science (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Reproductive Health (AREA)
Endocrinology (AREA)
Diabetes (AREA)
Pregnancy & Childbirth (AREA)
Gynecology & Obstetrics (AREA)
Urology & Nephrology (AREA)
Steroid Compounds (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Cosmetics (AREA)
Micro-Organisms Or Cultivation Processes Thereof (AREA)

NO19965516A 1994-06-23 1996-12-20 Anvendelse av sterolderivater til fremstilling av et preparat for regulering av meiose, forbindelser for anvendelse som terapeutika ogfremgangsmåte for regulering av meiose i en pattedyrkjönnscelle in vitro NO314534B1 (no)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
DK75394		1994-06-23
DK24195		1995-03-09
PCT/DK1995/000265 WO1996000235A1 (en)	1994-06-23	1995-06-23	Sterol derivatives used for regulation of meiosis

Publications (3)

Publication Number	Publication Date
NO965516D0 NO965516D0 (no)	1996-12-20
NO965516L true NO965516L (no)	1997-02-21
NO314534B1 NO314534B1 (no)	2003-04-07

Family

ID=26063596

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO19965516A NO314534B1 (no)	1994-06-23	1996-12-20	Anvendelse av sterolderivater til fremstilling av et preparat for regulering av meiose, forbindelser for anvendelse som terapeutika ogfremgangsmåte for regulering av meiose i en pattedyrkjönnscelle in vitro

Country Status (26)

Country	Link
US (1)	US5716777A (no)
EP (1)	EP0767798B1 (no)
JP (1)	JP3987105B2 (no)
KR (1)	KR100408369B1 (no)
CN (1)	CN1068333C (no)
AT (1)	ATE248852T1 (no)
AU (1)	AU694240B2 (no)
BG (1)	BG101067A (no)
BR (1)	BR9508074A (no)
CA (1)	CA2192941C (no)
CZ (1)	CZ289407B6 (no)
DE (1)	DE69531682T2 (no)
DK (1)	DK0767798T3 (no)
ES (1)	ES2204955T3 (no)
FI (1)	FI117159B (no)
HU (1)	HUT76343A (no)
IL (1)	IL114294A (no)
IS (1)	IS4404A (no)
MX (1)	MX9700174A (no)
NO (1)	NO314534B1 (no)
PL (1)	PL186688B1 (no)
RU (1)	RU2194510C2 (no)
SI (1)	SI9520077A (no)
SK (1)	SK165596A3 (no)
UA (1)	UA51622C2 (no)
WO (1)	WO1996000235A1 (no)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
PL322106A1 (en) *	1995-03-06	1998-01-05	Novo Nordisk As	Meiosis stimulation
PL185622B1 (pl) *	1995-06-23	2003-06-30	Novo Nordisk As	Zastosowanie związku steroidowego i sposób regulacji mejozy w komórce rozrodczej ssaka
AU6122696A (en) *	1995-06-23	1997-01-22	Novo Nordisk A/S	Meiosis regulating compounds
US6645953B2 (en) *	1995-06-23	2003-11-11	Novo Nordisk A/S	Meiosis regulating compounds
AU746878B2 (en)	1996-12-20	2002-05-02	Novo Nordisk A/S	Meiosis regulating compounds
US6177420B1 (en) *	1997-05-16	2001-01-23	Akzo Nobel N.V.	20-aralkyl-5α-pregnane derivatives
AU8535398A (en) *	1997-06-04	1998-12-21	Akzo Nobel N.V.	17beta-allyloxy(thio)alkyl-androstane derivatives for the modulation of meiosis
ES2181321T3 (es) *	1997-12-18	2003-02-16	Akzo Nobel Nv	Derivados 17beta-aril(arilmetil)oxi(tio)alquilandrostano.
IL139241A0 (en)	1998-05-13	2001-11-25	Novo Nordisk As	Meiosis regulating compounds
DE69913513T2 (de) *	1998-05-13	2004-09-30	Novo Nordisk A/S	Verwendung von verbindungen mit der fähigkeit die meiose zu regulieren
AU5408999A (en) *	1998-05-26	1999-12-13	Schering Aktiengesellschaft	Treatment of infertility with camp-increasing compounds alone or in combination with at least one meiosis-stimulating compound
AU4498299A (en) *	1998-06-19	2000-01-10	Novo Nordisk A/S	Meiosis regulating compounds
DE69903346T2 (de) *	1998-12-11	2003-01-30	Akzo Nobel N.V., Arnheim/Arnhem	22s-hydroxycholesta-8,14-dien derivate mit meiose regulierende aktivität
WO2000036132A1 (en)	1998-12-14	2000-06-22	Merck & Co., Inc.	Hiv integrase inhibitors
CZ20012866A3 (cs) *	1999-02-10	2002-01-16	Schering Aktiengesellschaft	Nenasycené cholestanové deriváty, farmaceutické kompozice obsahující tyto deriváty a pouľití těchto derivátů pro přípravu léčiv regulujících meiozu
CN1353617A (zh) *	1999-02-24	2002-06-12	诺沃挪第克公司	不孕症的治疗
EP1156821B1 (en) *	1999-02-24	2007-05-02	Novo Nordisk A/S	Treatment of infertility
BR0008536A (pt) *	1999-02-26	2001-11-06	Novo Nordisk As	Usos de um meio de cultura, e de pelo menos um mas, análogo de mas ou um aditivo ou aditivos, e, processo para fertilização in vitro
JP2002539134A (ja) *	1999-03-09	2002-11-19	アクゾ・ノベル・エヌ・ベー	減数分裂の阻害のための２２ｒ−ヒドロキシコレスタ−８，１４−ジエン誘導体
DE60023324T2 (de) *	1999-09-16	2006-07-20	Novo Nordisk A/S	Zusammensetzung zur in-vitro befruchtung
EP1127890A1 (en)	2000-02-22	2001-08-29	Schering Aktiengesellschaft	Steroid derivatives with an additional ring annulated to ring A and use of these derivatives for the preparation of meiosis regulating medicaments
AU2001240624A1 (en) *	2000-02-25	2001-09-03	Novo-Nordisk A/S	Improvement of implantation rate
AU3376501A (en) *	2000-02-25	2001-09-03	Novo Nordisk A/S	Improvement of implantation rate
CA2404822A1 (en) *	2000-05-18	2001-11-22	Novo Nordisk A/S	Fertilization of aged oocytes
EP1245572A1 (en)	2001-03-26	2002-10-02	Schering Aktiengesellschaft	Aminosterol compounds, their use in the preparation of meiosis-regulating medicaments and method for their preparation
AU2003203145A1 (en) *	2002-02-22	2003-09-09	Novo Nordisk A/S	A transducer of mas signalling
US9376462B2 (en)	2010-10-01	2016-06-28	Indiana University Research And Technology Corporation	Process for preparing delta-7,9(11) steroids from Ganoderma lucidum and analogs thereof
US9165822B2 (en)	2013-03-11	2015-10-20	Taiwan Semiconductor Manufacturing Company, Ltd.	Semiconductor devices and methods of forming same
EA024619B1 (ru) *	2014-11-21	2016-10-31	Эльвин Гаджи оглы Керимли	ФРАКСИНОСТЕРИН - 24β-ЭТИЛХОЛЕСТА-20-КАРБОКСИ-6(7),8(9)-ДИЕН 3β-ОЛА И ЕГО ПРОИЗВОДНОЕ

1995
- 1995-05-23 US US08/448,217 patent/US5716777A/en not_active Expired - Fee Related
- 1995-06-23 RU RU97101087/14A patent/RU2194510C2/ru not_active IP Right Cessation
- 1995-06-23 WO PCT/DK1995/000265 patent/WO1996000235A1/en not_active Ceased
- 1995-06-23 MX MX9700174A patent/MX9700174A/es not_active IP Right Cessation
- 1995-06-23 JP JP50272496A patent/JP3987105B2/ja not_active Expired - Lifetime
- 1995-06-23 PL PL95317830A patent/PL186688B1/pl not_active IP Right Cessation
- 1995-06-23 HU HU9603584A patent/HUT76343A/hu not_active Application Discontinuation
- 1995-06-23 IL IL11429495A patent/IL114294A/en not_active IP Right Cessation
- 1995-06-23 CN CN95193731A patent/CN1068333C/zh not_active Expired - Fee Related
- 1995-06-23 KR KR1019960707361A patent/KR100408369B1/ko not_active Expired - Fee Related
- 1995-06-23 ES ES95922448T patent/ES2204955T3/es not_active Expired - Lifetime
- 1995-06-23 AU AU27343/95A patent/AU694240B2/en not_active Ceased
- 1995-06-23 UA UA96124771A patent/UA51622C2/uk unknown
- 1995-06-23 CZ CZ19963725A patent/CZ289407B6/cs not_active IP Right Cessation
- 1995-06-23 CA CA002192941A patent/CA2192941C/en not_active Expired - Fee Related
- 1995-06-23 SI SI9520077A patent/SI9520077A/sl unknown
- 1995-06-23 DE DE69531682T patent/DE69531682T2/de not_active Expired - Fee Related
- 1995-06-23 EP EP95922448A patent/EP0767798B1/en not_active Expired - Lifetime
- 1995-06-23 BR BR9508074A patent/BR9508074A/pt not_active IP Right Cessation
- 1995-06-23 SK SK1655-96A patent/SK165596A3/sk unknown
- 1995-06-23 DK DK95922448T patent/DK0767798T3/da active
- 1995-06-23 AT AT95922448T patent/ATE248852T1/de not_active IP Right Cessation
1996
- 1996-12-18 BG BG101067A patent/BG101067A/xx unknown
- 1996-12-20 NO NO19965516A patent/NO314534B1/no unknown
- 1996-12-20 FI FI965144A patent/FI117159B/fi active IP Right Grant
- 1996-12-23 IS IS4404A patent/IS4404A/is unknown

Also Published As

Publication number	Publication date
NO965516D0 (no)	1996-12-20
CA2192941C (en)	2009-04-14
HU9603584D0 (en)	1997-02-28
JP3987105B2 (ja)	2007-10-03
JPH10502060A (ja)	1998-02-24
KR100408369B1 (ko)	2004-04-28
US5716777A (en)	1998-02-10
HUT76343A (en)	1997-08-28
IL114294A0 (en)	1995-10-31
AU694240B2 (en)	1998-07-16
ES2204955T3 (es)	2004-05-01
MX9700174A (es)	1997-04-30
CZ289407B6 (cs)	2002-01-16
CZ372596A3 (en)	1997-07-16
WO1996000235A1 (en)	1996-01-04
IL114294A (en)	2002-09-12
RU2194510C2 (ru)	2002-12-20
FI965144L (fi)	1997-02-20
AU2734395A (en)	1996-01-19
IS4404A (is)	1996-12-23
PL317830A1 (en)	1997-04-28
FI965144A0 (fi)	1996-12-20
DE69531682D1 (de)	2003-10-09
NO314534B1 (no)	2003-04-07
ATE248852T1 (de)	2003-09-15
DK0767798T3 (da)	2003-12-22
EP0767798B1 (en)	2003-09-03
SI9520077A (sl)	1998-06-30
SK165596A3 (en)	1997-08-06
CA2192941A1 (en)	1996-01-04
DE69531682T2 (de)	2004-07-15
CN1151164A (zh)	1997-06-04
FI117159B (fi)	2006-07-14
EP0767798A1 (en)	1997-04-16
PL186688B1 (pl)	2004-02-27
UA51622C2 (uk)	2002-12-16
BG101067A (en)	1997-08-29
CN1068333C (zh)	2001-07-11
BR9508074A (pt)	1997-08-12

Publication	Publication Date	Title
NO965516D0 (no)	1996-12-20	Sterolderivater anvendt til regulering av meiose
IT1285770B1 (it)	1998-06-18	Composti corticoidei
BG104315A (en)	2000-12-29	Prostaglandine agonists and their application for the treatment of osteal diseases
TR199901174T2 (xx)	1999-08-23	Yeni heterosiklilmetil-ikameli pirazol t�revleri.
CA2160966A1 (fr)	1996-04-22	Derives de piperidine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
NL1002835A1 (nl)	1996-10-14	Synergistisch stabilisatormengsel.
UA34466C2 (uk)	2001-03-15	Засіб для несистемної боротьби з паразитуючими комахами
CY1108610T1 (el)	2014-04-09	Πεπτιδια της il-2 και παραγωγα αυτων και χρηση αυτων ως θεραπευτικοι παραγοντες
MX9700885A (es)	1998-04-30	Nuevas heteroariloxazolidinonas.
ATE231872T1 (de)	2003-02-15	Thiazolopyrimidinderivate
MX9704037A (es)	1998-02-28	1,1-dioxidos de 1,2,5-tiadiazolidin-3-ona 2-substituida y composiciones y metodo de uso de los mismos.
ES2172937T3 (es)	2002-10-01	21-hidroxi-6,19-oxidoprogesterona(21oh-6op) como medicamento para tratar el exceso de glucocorticoides.
NO965444D0 (no)	1996-12-18	Triterpen-derivat samt medikamentell sammensetning omfattende dette
MY128260A (en)	2007-01-31	Cyclopentane-and-pentene-b-amino acids
ES2132556T3 (es)	1999-08-16	Nuevo derivado de benzo-tiadiazina, su procedimiento de preparacion y las composiciones farmaceuticas que lo contienen.
MX9704034A (es)	1998-02-28	Derivados y composiciones de 1,1-dioxido de 2-arilcarboniloximetil-1,2,5-tiadiazolidin-3-ona substituido y metodo de uso.
BG100248A (bg)	1996-07-31	Инхибитори на скваленсинтетаза
DE69407057D1 (de)	1998-01-08	1,3.5 (10) - estratriene derivate mit oraler wirkung
ATE227122T1 (de)	2002-11-15	Stabilisierte tablettenformulierung
UY24915A1 (es)	2000-12-29	Derivados de benzoxazindiona, aplicación de los mismos y medicamentos que los contienen
NO923266D0 (no)	1992-08-20	Heksahydrobenzo(f)quinolinoner
NO20020914D0 (no)	2002-02-25	Alkoksy-substituerte benzimidazolforbindelser, preparater inneholdende slike samt anvendelser derav
DK0720597T3 (da)	1998-10-07	Triarylethylenderivater til terapeutisk anvendelse
NO961429D0 (no)	1996-04-11	Fremgangsmåte for fremstilling av kinolonholdige, orale preparater
DK0967986T3 (da)	2003-02-10	Anvendelse af humant alfa1-surt glycoprotein til fremstilling af et farmaceutisk præparat